Key result
Beta-blockers, particularly bisoprolol, reduce sympathetic nerve activity and lower blood pressure in patients with hypertension.
Why the study?
Do beta-blockers reduce sympathetic overdrive and cardiovascular risk in patients with hypertension?
Do beta-blockers reduce sympathetic overdrive and cardiovascular risk in patients with hypertension?
While beta-blockers like bisoprolol effectively reduce sympathetic overdrive in hypertension, their overall impact on mortality as first-line therapy may be inferior to other antihypertensive classes.
Answers are grounded in this paper and cite their sources.
May support bisoprolol in hypertension; leaves open randomized confirmation of sympathetic effects.
Sympathetic neural factors played an important role in homeostatic blood pressure control. Dysregulation in sympathetic function may favor the development and progression of the hypertensive state. Beta-blocker, as one of antihypertensive drugs, provides several positive effects to hinder overactivity of sympathetic nerve in patients with hypertension.
No takes yet. Share an insight, caveat, or question.
Lucia Kris Dinarti (2019) conducted a review in Hypertension. Beta-blockers (Bisoprolol) was evaluated. Beta-blockers, particularly bisoprolol, reduce sympathetic nerve activity and lower blood pressure in patients with hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: